REQUEST A DEMO
Total
USD $0.00
Search more companies

AS Bravo Pharmaceuticals (Estonia)

Main Activities: Pharmaceutical Preparation Manufacturing | Outpatient Care Centers
Full name: AS Bravo Pharmaceuticals Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

AS Bravo Pharmaceuticals is based in Estonia, with the head office in Viimsi. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on November 29, 2016. It currently has a total number of 2 (2024) employees. The latest financial highlights indicate a net sales revenue increase of 44.76% in 2024. Its total assets decreased by 4.85% over the same period. The net profit margin of AS Bravo Pharmaceuticals increased by 180.76% in 2024.

Headquarters
Paadi tee 3 Haabneeme alevik
Viimsi; Harju county; Postal Code: 74001

Contact Details: Purchase the AS Bravo Pharmaceuticals report to view the information.

Basic Information
Total Employees:
Purchase the AS Bravo Pharmaceuticals report to view the information.
Registered Capital:
Purchase the AS Bravo Pharmaceuticals report to view the information.
Financial Auditors:
Purchase the AS Bravo Pharmaceuticals report to view the information.
Incorporation Date:
November 29, 2016
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Company Performance
Financial values in the chart are available after AS Bravo Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
44.76%
Total operating revenue
44.76%
Operating profit (EBIT)
16.42%
EBITDA
17.93%
Net Profit (Loss) for the Period
16.48%
Total assets
-4.85%
Total equity
-63.01%
Operating Profit Margin (ROS)
180.77%
Net Profit Margin
180.76%
Return on Equity (ROE)
-94.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?